Turning Point Brands (NYSE: TPB) reported Q2 EPS of $0.98, $0.25 better than the analyst estimate of $0.73. Revenue for the quarter came in at $116.6 million versus the consensus estimate of $107.3 million.

Company increasing full-year consolidated Modern Oral sales guidance to $100.0 – 110.0 million (from $80.0 – 95.0 million)

For earnings history and earnings-related data on Turning Point Brands (TPB) click here.